BIOMAT Database Logo BIOMAT Database Logo

Age does not influence acute toxicity during radiotherapy dose escalation for prostate cancer. 2006

A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010315 Particle Accelerators Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Betatrons,Linear Accelerators,Accelerator, Linear,Accelerator, Particle,Accelerators, Linear,Accelerators, Particle,Betatron,Linear Accelerator,Particle Accelerator
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Dose escalation study with two different hypofractionated intensity modulated radiotherapy techniques for localized prostate cancer: acute toxicity.
June 2010, Technology in cancer research & treatment,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Dose Escalation or Not-Does Age Matter?
December 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
March 2009, International journal of radiation oncology, biology, physics,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Hazards of dose escalation in prostate cancer radiotherapy.
December 2003, International journal of radiation oncology, biology, physics,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer.
April 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Dose escalation in prostate cancer using intensity modulated neutron radiotherapy.
May 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer.
December 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Radiation dose escalation for prostate cancer
December 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Radiation dose escalation for prostate cancer.
December 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Dhadda, and D Lakshmanan, and M Sokal, and S Sundar
Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer.
June 2005, Urology,
Copied contents to your clipboard!